NN6561
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2024
A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.
(clinicaltrials.gov)
- P1 | N=51 | Completed | Sponsor: Novo Nordisk A/S | N=80 ➔ 51 | Trial completion date: Oct 2024 ➔ Jul 2024 | Recruiting ➔ Completed
Enrollment change • Trial completion • Trial completion date • Hepatology
1 to 1
Of
1
Go to page
1